Arch Oncology Investors
Portland, US · Founded 2021 · Delaware LLC
Founders & leadership
NT
Nicholas T WalrodManager
AL
Anthony L ArnerichManager
Reported raises · per SEC filings
Form D private placements$11M disclosed across 1 round · 2021
▶$11MraisedMay 2021 · 40 investors · Biotechnology
▶$11MraisedMay 2021 · 40 investors · Biotechnology
Officers, directors & promoters on the filing
- Nicholas T WalrodExecutive Officer
- Anthony L ArnerichExecutive Officer
- Offering amount
- $11M
- Amount sold
- $11M
- Minimum investment
- $25K
- Placement agents
- Arch Oncology Investors, LLC
- First sale
- Apr 2021
- Incorporated
- Limited Liability Company, Delaware, 2021
- Federal exemptions
- 3C, 3C.1
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Arch Oncology Investors raised?
- Arch Oncology Investors has disclosed $11M raised across 1 round.
- Where is Arch Oncology Investors headquartered?
- Arch Oncology Investors is headquartered in Portland, US.